Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Expedio Hereditary Cancer Predisposition Screening Assay Kailos Genetics United States | 40 | 31 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Genesys Diagnostics Genesys Diagnostics, Inc. United States | 40 | 39 |
|
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 37 | 33 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 2 | 1 |
|
Hereditary leiomyomatosis and renal cell cancer Molecular Genetics Laboratory North York General Hospital Canada | 1 | 1 |
|
Familial renal cancer panel (15 genes) Molecular Genetics Laboratory North York General Hospital Canada | 11 | 15 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Myriad Genetics, Inc. United States | 32 | 46 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
FH - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.